Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

ClinicalTrials.gov ID: NCT00675025

Public ClinicalTrials.gov record NCT00675025. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 2:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study to Evaluate the Safety of Donepezil Hydrochloride((Aricept®) for up to 1 Year in the Treatment of Cognitive Dysfunction Exhibited by Children With Down Syndrome-Follow-up to a 10-Week,Double-Blind,Placebo-Controlled Trial

Study identification

NCT ID
NCT00675025
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eisai Inc.
Industry
Enrollment
117 participants

Conditions and interventions

Conditions

Interventions

  • Donepezil hydrochloride (Aricept) Drug

Drug

Eligibility (public fields only)

Age range
10 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 3, 2008
Primary completion
Nov 12, 2008
Completion
Dec 14, 2008
Last update posted
Mar 28, 2021

2008

United States locations

U.S. sites
31
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Phoenix Children's Hospital Phoenix Arizona 85016
Child Neurology Associates, PC Little Rock Arkansas 72205
Midwest Children's Health Research Institute Los Angeles California 90048
Children's Hospital and Research Center at Oakland Oakland California 94609
University of California, Irvine Medical Center Orange California 92868
UCSD Pediatric Pharmacology Research Unit San Diego California 92123
Rocky Mountain Pediatrics, P.C. Lakewood Colorado 80214
Neufeld Medical Group, Inc. Fort Myers Florida 33912
Miami Children's Hospital Miami Florida 33155-3009
Miami Children's Hospital - Medical Genetics and Neuro-Developmental Center Miami Florida 33155
Phoenix Children's Hospital Miami Florida 33155
Clinical Studies Centers, LLC St. Petersburg Florida 33709
Northwest Clinical Research Center West Palm Beach Florida 33407
Road Runner Research Atlanta Georgia 30342
Hurley Medical Center Flint Michigan 48503
Saint Mary's Health Care Grand Rapids Michigan 49503
Washington University School of Medicine Grand Rapids Michigan 49503
Regions Hospital Saint Paul Minnesota 55101-2595
Northwest Clinical Research Center St Louis Missouri 63110
Meridien Research Lincoln Nebraska 68504
Clinical Research Center of New Jersey Voorhees Township New Jersey 08043
Division of Genetics and Developmental Behavior Durham North Carolina 27710
Metrohealth Medical Center Cleveland Ohio 44109
Valko and Associates Toledo Ohio 43606
Office of Lazlo Mate Tulsa Oklahoma 74104
Medical Univ of South Carolina Charleston South Carolina 29425
Vanderbilt Children's Hospital Nashville Tennessee 37232-9225
Down Syndrome Clinic of Houston Houston Texas 77030
Alamo City Clinical Research, LLC San Antonio Texas 78258
Community Research Foundation San Antonio Texas 78258
Neuropsychiatric Research Center of Southwest Florida Bellevue Washington 98004

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00675025, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 28, 2021 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00675025 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →